RAY SUMITA enters CUE BIOPHARMA, INC. with 54.59K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/11/2026ACC: 0001579629-26-000002
OfficerOther· Chief Legal Compliance Officer
Since Jun 2026
54.59K
Baseline shares
100% direct
54.59K
Direct ownership
1 position
109.18K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned54.59K
Total
54.59K direct54.59K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 54.59K | Direct |
| Total | 54.59K | 54.59K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
109.18K
Shares owned
N/A
Exercise price
30.42
Expiration
—
Exercise window
—
Total
Underlying
109.18K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 30.42 | — | — | 109.18K | N/A |
| Total | 109.18K | 0.00 | ||||